Encision Inc. logo

Encision Inc. (ECIA)

Market Open
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 04
+0.01
+22%
$
626.24K Market Cap
- P/E Ratio
- Div Yield
7,000 Volume
0 Eps
$ 0.04
Previous Close
Add Transaction
Day Range
0.04 0.12
Year Range
0 0.4
Want to track ECIA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ECIA trading today higher at $0.04, an increase of 22% from yesterday's close, completing a monthly increase of 2,746.6667% or $0.04. Over the past 12 months, ECIA stock lost -69.5%.
ECIA is not paying dividends to its shareholders.
The last earnings report, released on Nov 13, 2025, missed the consensus estimates by -0.02%. On average, the company has fell short of earnings expectations by -0.0107%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

ECIA Chart

People also search for

WM Technology, Inc.
$ 0.4
-3.5904%
Realbotix Corp.
$ 0.21
+2.4166%
Luna Innovations Incorporated
$ 1.26
-0.7874%
Marpai Inc.
$ 2.18
-0.4566%
Argo Corp.
$ 0.24
+2.7579%
Encision Reports Second Quarter Fiscal Year 2025 Results

Encision Reports Second Quarter Fiscal Year 2025 Results

BOULDER, CO / ACCESSWIRE / November 15, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2025 second quarter that ended September 30, 2024. The Company posted quarterly product net revenue of $1.65 million and service net revenue of $101 thousand, or total net revenue of $1.75 million for a quarterly net loss of $170 thousand, or $(0.01) per diluted share.

Accesswire | 1 year ago
Encision Signs Master Services Agreement with Vicarious Surgical Inc.

Encision Signs Master Services Agreement with Vicarious Surgical Inc.

BOULDER, CO / ACCESSWIRE / August 21, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray energy burns in minimally invasive surgery, today announced that Encision has signed a Master Services Agreement ("Agreement") with Vicarious Surgical Inc. ("Vicarious"). The Agreement commenced July 8, 2024 and will continue thereafter until terminated by certain actions of either party.

Accesswire | 1 year ago
Encision Reports First Quarter Fiscal Year 2025 Results

Encision Reports First Quarter Fiscal Year 2025 Results

BOULDER, CO / ACCESSWIRE / August 15, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2025 first quarter that ended June 30, 2024. The Company posted quarterly product net revenue of $1.59 million and service net revenue of $39 thousand, or total net revenue of $1.63 million for a quarterly net income of $22 thousand, or $0.00 per diluted share.

Accesswire | 1 year ago

Encision Inc. (ECIA) FAQ

What is the stock price today?

The current price is $0.04.

On which exchange is it traded?

Encision Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is ECIA.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 626.24K.

Has Encision Inc. ever had a stock split?

No, there has never been a stock split.

Encision Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Robert H. Fries CEO
OTC PINK Exchange
29254Q104 CUSIP
US Country
23 Employees
- Last Dividend
- Last Split
25 Jun 1996 IPO Date

Overview

Encision Inc. is a distinguished player in the medical device sector, specializing in the design, development, manufacture, and marketing of patented surgical instruments within the United States. The core of Encision's innovation revolves around its proprietary active electrode monitoring (AEM) technology, which significantly enhances patient safety and outcomes in laparoscopic surgeries. Established in 1991 and headquartered in Boulder, Colorado, Encision has positioned itself as a vital contributor to the field of minimally invasive surgery through its commitment to innovation, safety, and the continuous improvement of surgical outcomes.

Products and Services

Encision's portfolio is particularly geared towards enhancing laparoscopic surgical procedures. The company's offerings can be categorized into specific product lines, each designed with the aim of improving surgical efficiency, safety, and patient outcomes. The detailed overview of their products and services includes:

  • AEM Surgical Instruments: This core product line comprises a variety of endo-mechanical instruments such as scissors, graspers, and dissectors. Additionally, fixed-tip electrodes and suction-irrigation electrodes are offered, all embedded with AEM technology to ensure safer surgical outcomes by reducing the risk of unintended thermal injury.
  • Handles: Designed for advanced laparoscopic procedures, Encision offers a range of handles that feature stiffer shafts and ergonomic designs. These are engineered to enhance the precision and comfort of surgical operations, facilitating a smoother surgical process with reduced operator fatigue.
  • AEM EndoShield 2 Burn Protection System: This innovative system represents a significant advancement in surgery safety, offering active protection against potential burns from electrical mishaps during laparoscopic procedures. The EndoShield 2 system underscores Encision's commitment to patient safety and the elimination of preventable surgical complications.
  • AEM Monitor Product Line: To complement its suite of instruments, Encision provides a line of monitors that work in conjunction with the AEM instruments. These monitors are crucial for the real-time surveillance of electrical currents during surgery, ensuring that the AEM system's safety features are fully operational, thereby enhancing the overall safety of laparoscopic procedures.

These products are made available to the healthcare sector through a strategic network of direct and independent sales representatives, ensuring that Encision's innovative solutions are accessible to hospitals and surgical centers across the nation.

Contact Information

Address: 6797 Winchester Circle
Phone: 303 444 2600